Posted Sep. 8, 2011 at 12:37 p.m.

Premium Lock Losers in Treximet patent decision are appealing

Published: 2011-09-08 12:37:20
Updated: 2011-09-08 12:37:20

Tags: Pozen, GSK

A securities filing by patent-holder Pozen says that generic drug-makers are appealing a ruling by a judge in that Pozen had exclusive rights to Treximet....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders